These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 10498834

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
    Boulay D, Duterte-Boucher D, Leroux-Nicollet I, Naudon L, Costentin J.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):330-7. PubMed ID: 8764367
    [Abstract] [Full Text] [Related]

  • 23. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides.
    Silvia CP, Jaber M, King GR, Ellinwood EH, Caron MG.
    Neuroscience; 1997 Feb; 76(3):737-47. PubMed ID: 9135047
    [Abstract] [Full Text] [Related]

  • 24. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A, Zhou G, Hoepping A, Mukhopadhyaya J, Johnson KM, Zhang M, Kozikowski AP.
    J Med Chem; 2002 Apr 25; 45(9):1930-41. PubMed ID: 11960503
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Brain dopamine transporter: gender differences and effect of chronic haloperidol.
    Rivest R, Falardeau P, Di Paolo T.
    Brain Res; 1995 Sep 18; 692(1-2):269-72. PubMed ID: 8548314
    [Abstract] [Full Text] [Related]

  • 31. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
    Paris I, Martinez-Alvarado P, Perez-Pastene C, Vieira MN, Olea-Azar C, Raisman-Vozari R, Cardenas S, Graumann R, Caviedes P, Segura-Aguilar J.
    J Neurochem; 2005 Mar 18; 92(5):1021-32. PubMed ID: 15715653
    [Abstract] [Full Text] [Related]

  • 32. In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands.
    Rijks LJ, Booij J, Doornbos T, Boer GJ, Ronken E, de Bruin K, Vermeulen RJ, Janssen AG, Van Royen EA.
    Synapse; 1996 Jul 18; 23(3):201-7. PubMed ID: 8807748
    [Abstract] [Full Text] [Related]

  • 33. Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter.
    Gaffaney JD, Vaughan RA.
    Mol Pharmacol; 2004 Mar 18; 65(3):692-701. PubMed ID: 14978248
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
    Kimmel HL, Carroll FI, Kuhar MJ.
    Neuropharmacology; 2000 Feb 14; 39(4):578-85. PubMed ID: 10728879
    [Abstract] [Full Text] [Related]

  • 37. The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage.
    Prasad BM, Amara SG.
    J Neurosci; 2001 Oct 01; 21(19):7561-7. PubMed ID: 11567046
    [Abstract] [Full Text] [Related]

  • 38. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
    Zhu J, Mactutus CF, Wallace DR, Booze RM.
    J Pharmacol Exp Ther; 2009 Jun 01; 329(3):1071-83. PubMed ID: 19325033
    [Abstract] [Full Text] [Related]

  • 39. Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc.
    Stanic D, Parish CL, Zhu WM, Krstew EV, Lawrence AJ, Drago J, Finkelstein DI, Horne MK.
    J Neurochem; 2003 Jul 01; 86(2):329-43. PubMed ID: 12871574
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.